Mahamaya Lifesciences Ltd (MAHALIFE) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Mahamaya Lifesciences Ltd reported sales of ₹163 Cr, operating profit of ₹15 Cr (OPM 9%) and net profit of ₹8 Cr for the quarter ended Sep 2025. Figures in ₹ crore, consolidated where available.
MAHALIFE quarterly results (₹ Cr) Metric Sep 2024 Sep 2025 Sales 146 163 Expenses 133 148 Operating Profit 13 15 OPM 9% 9% Other Income 1 1 Interest 4 4 Depreciation 1 1 Profit before tax 10 11 Tax 27% 27% Net Profit 7 8 EPS in Rs 4.08 4.71
MAHALIFE profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sales 90 137 161 264 Expenses 84 128 148 241 Operating Profit 6 9 13 23 OPM 7% 6% 8% 9% Other Income 0 0 1 3 Interest 2 3 6 7 Depreciation 1 1 1 2 Profit before tax 4 5 7 17 Tax 27% 26% 27% 25% Net Profit 3 4 5 13 EPS in Rs 21.78 30.03 41.8 7.28 Dividend Payout 0% 0% 0% 0%
MAHALIFE balance sheet (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025 Equity Capital 1 1 1 18 18 Reserves 14 18 23 32 40 Borrowings 19 24 55 58 68 Other Liabilities 21 34 33 81 110 Total Liabilities 56 78 112 188 236 Fixed Assets 20 21 21 27 31 CWIP 2 2 3 4 0 Investments 0 0 0 0 0 Other Assets 34 54 88 157 205 Total Assets 56 78 112 188 236
MAHALIFE cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Cash from Operating Activity 2 1 -23 1 Cash from Investing Activity -3 -3 -2 -8 Cash from Financing Activity 1 2 24 9 Net Cash Flow 0 1 0 1 Free Cash Flow -1 -2 -25 -8 CFO/OP 56% 24% -163% 12%
MAHALIFE ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Debtor Days 37 25 64 67 Inventory Days 93 109 137 167 Days Payable 83 87 61 92 Cash Conversion Cycle 47 48 140 142 Working Capital Days 8 9 14 29 ROCE - 20% 21% 26%